SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-23-007727
Filing Date
2023-03-13
Accepted
2023-03-13 17:02:15
Documents
110
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K cpix-20221231.htm   iXBRL 10-K 2213377
2 EX-4.11 a2022q4exhibit411.htm EX-4.11 29080
3 EX-10.11 a2022-10kxex1011ajkazimi.htm EX-10.11 37360
4 EX-10.14 a2022-10kxex1014johnhamm.htm EX-10.14 37141
5 EX-10.15 a2022-10kxex1015jimherman.htm EX-10.15 37624
6 EX-23.2 a2022-xex232consentofforvi.htm EX-23.2 2408
7 EX-31.1 a2022-10kxexhibit311.htm EX-31.1 12889
8 EX-31.2 a2022-10kxexhibit312.htm EX-31.2 12370
9 EX-32.1 a2022-10kxexhibit321.htm EX-32.1 6623
15 GRAPHIC cpix-20221231_g1.jpg GRAPHIC 109898
16 GRAPHIC ssmithsign.jpg GRAPHIC 11999
  Complete submission text file 0001628280-23-007727.txt   10404080

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cpix-20221231.xsd EX-101.SCH 81026
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cpix-20221231_cal.xml EX-101.CAL 93274
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cpix-20221231_def.xml EX-101.DEF 315491
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cpix-20221231_lab.xml EX-101.LAB 847905
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cpix-20221231_pre.xml EX-101.PRE 551182
104 EXTRACTED XBRL INSTANCE DOCUMENT cpix-20221231_htm.xml XML 1518890
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33637 | Film No.: 23728059
SIC: 2834 Pharmaceutical Preparations